Clinical Trial: NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice

U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07036718) titled 'NIS PDC the Efficacy and Safety of Iptacopan in Adults in Routine Clinical Practice' on June 17.

Brief Summary: This is a prospective, non-interventional, multicenter study to evaluate the efficacy and safety of iptacopan in patients with PNH in real-world settings in Russia.

Study Start Date: July 31

Study Type: OBSERVATIONAL

Condition: Paroxysmal Nocturnal Hemoglobinuria

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Disclaimer: Curated by HT Syndication....